Tag: Cymerus

August 30, 2018

Cynata CYP-001 Stem Cell Therapy Meets All Safety and Efficacy Endpoints in Phase 1 Trial in GvHD

Australian stem cell and regenerative medicine company Cynata Therapeutics (ASX: CYP) is pleased to announce that CYP-001, its lead Cymerus...
June 12, 2018

Cynata Reports Positive Six-Month Data from Cohort A in Phase 1 Trial of CYP-001 in GvHD

Australian stem cell and regenerative medicine company Cynata Therapeutics Limited (ASX:CYP) is pleased to announce positive safety and sustained overall...